San Angelo,Texas Certs of Obligation Rtd 'A-' by S&P Apr 98

  • ID: 1815165
  • April 1998
  • Region: Texas
  • Standard & Poors
1 of 3

NY -- Standard & Poor's CreditWire 4/30/98 – Standard & Poor's today assigned its double-'A'-minus rating to San Angelo, Texas' combination tax and revenue certificates of obligation series 1998 dated May 1, 1998 due June 15, 2018. The bonds are scheduled to sell May 5, 1998. In addition, Standard & Poor's affirmed its double-'A'-minus rating on the city's G.O. bonds. The city's rating reflects a regional service and trade economy, sound financial performance and reserve levels, and low debt burden. San Angelo (population 91,800) serves as an important commercial center for the ranching and farming industry covering a trade area of 14 counties in west Texas. Anchoring the economy is Goodfellow Air Force base and its 3,900 personnel involved in...

Companies mentioned in this report are:
- San Angelo

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- San Angelo

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.